Nurse Practitioner, Gerontology · Houston, TX
NPI
1043702467
Since 2018
Specialty
Nurse Practitioner, Gerontology
Code 363LG0600X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5530 W Ridgecreek Dr Ste 250
Houston, TX, 77053
Phone (346) 223-2195
Groups this clinician bills Medicare through
Medicare paid, 2024
$95K
988 services
Medicare patients, 2024
221
Average age 68
Drug cost, 2024
$1.3M
12,073 prescriptions
Company payments, 2025
$606
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ndubuisi D Odimegwu was code 99349 (home e&m - new and established), 655 times for 167 patients. In total Ndubuisi D Odimegwu billed 988 services in 7 codes, and Medicare paid $95K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99349 Home E&M - New and Established | Office | 655 | 167 | $83.64 | $55K |
| 99350 Home E&M - New and Established | Office | 203 | 95 | $118.01 | $24K |
| 99345 Home E&M - New and Established | Office | 126 | 125 | $129.08 | $16K |
By year: 2022 $20K for 248 services; 2023 $38K for 389 services; 2024 $95K for 988 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ndubuisi D Odimegwu prescribed most often to Medicare patients was Gabapentin, with 635 prescriptions and refills. In total Ndubuisi D Odimegwu wrote 12,073 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 635 | 653 | 148 | $4,762 |
| Atorvastatin Calcium Generic | 579 | 607 | 136 | $1,991 |
| Trazodone Hcl Generic | 441 | 446 | 103 | $1,324 |
| Quetiapine Fumarate Generic | 388 | 395 | 82 | $3,622 |
| Montelukast Sodium Generic | 306 | 323 | 61 | $1,222 |
| Amlodipine Besylate Generic | 285 | 302 | 74 | $695 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 278 | 301 | 81 | $8,507 |
| Losartan Potassium Generic | 270 | 272 | 69 | $969 |
| Hydrochlorothiazide Generic | 239 | 245 | 46 | $627 |
| Risperidone Generic | 237 | 240 | 52 | $2,323 |
| Mirtazapine Generic | 233 | 239 | 53 | $2,190 |
| Metformin Hcl Generic | 233 | 233 | 48 | $706 |
| Famotidine Generic | 232 | 245 | 46 | $1,934 |
| Benztropine Mesylate Generic | 232 | 232 | 51 | $2,614 |
| Divalproex Sodium Generic | 220 | 222 | 50 | $3,121 |
Brand drugs: 1,360 claims; generic drugs: 10,690 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ndubuisi D Odimegwu $606 ($606 in general payments such as food, travel and fees) from 7 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $193.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.